C h a p t e r 7
Neoplasia
157
50. Miser WF. Cancer screening in the primary care setting.
Prim Care
2007;34:137–167.
51. Smith RA, Brooks D, Cokkinides V, et al. Cancer screening in the
United States, 2013: a review of current American Cancer Society
guidelines, current issues in cancer screening and lung cancer
screening.
CA Cancer J Clin.
2013;63(2):88–105.
52. Rosenberg SA. Cancer management: surgical oncology:
general issues. In: DeVita VT Jr, Lawrence TS, Rosenberg
SA, eds.
Cancer: Principles and Practice of Oncology
. 9th ed.
Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams &
Wilkins; 2011:268–276.
53. Jeremic B. Radiation therapy.
Hematol Oncol Clin North Am
2004;18:1–12.
54. Morgan MA, Ten Haken RK, Lawrence TS. Radiation oncology.
In: DeVita VT Jr, Lawrence TS, Rosenberg SA, eds.
Cancer:
Principles and Practice of Oncology
. 9th ed. Philadelphia,
PA: Wolters Kluwer Health | Lippincott Williams & Wilkins;
2011:289–311.
55. Willers H, Held KD. Introduction to clinical radiation biology.
Hematol Oncol Clin North Am
. 2006;20:1–24.
56. Hogle WP. The state of the art in radiation therapy.
Semin Oncol
Nurs.
2006;22(4):212–220.
57. Ikushima H. Radiation therapy: state of the art and the future.
J Med Invest
2010;97:1–11.
58. Chu E, Sartorelli AC. Cancer chemotherapy. In: Katzung BG,
eds.
Basic and Clinical Pharmacology
. 10th ed. New York,
NY. McGraw-Hill; 2012:949–975.
59. DeVita VT Jr, Lawrence TS, Rosenberg SA, eds.
Cancer: Principles
and Practice of Oncology
. 9th ed. Philadelphia, PA: Wolters
Kluwer Health/Lippincott Williams & Wilkins; 2011:360–498.
60. Neuss MN, Polocich M, McNiff K, et al. 2013 updated
American Society of Clinical Oncology/Oncology Nursing
Society chemotherapy administration safety standards including
standards for safe administration and management of oral
chemotherapy.
Oncol Nurs Forum.
2013;40(3):325–233.
61. Hawkins R. Hormone therapy in cancer.
Oncol Nurs Updates.
2002;9(3):1–16.
62. Altundag K, Ibrahim NK. Aromatase inhibitors in breast cancer:
an overview.
Oncologist
. 2006;11:553–562.
63. Kuroki M, Miyamoto S, Morisaki T, et al. Biological response
modifiers in cancer biotherapy.
Anticancer Res
. 2012;32:
2229–2233.
64. Kirkwood JM, Butterfield LH, Tarhini A, et al. Immunotherapy
in cancer 2012.
CA Cancer J Clin.
2012;62(5):309–335.
65. Robinson MK, Borghael H, Adams GP, et al. Monoclonal
antibodies. In: DeVita VT Jr, Lawrence TS, Rosenberg SA,
eds.
Cancer: Principles and Practice of Oncology
. 9th ed.
Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams &
Wilkins; 2011:499–507.
66. Sharkey RM, Goldenberg DM. Targeted therapy of cancer: new
prospects for antibodies and immunoconjugates.
CA Cancer J
Clin
. 2006;56:226–243.
67. Goetsch CM. Genetic tumor profiling and genetically targeted
cancer therapy.
Semin Oncol Nurs.
2011;27(3):34–44.
68. Asselin BL. Epidemiology of childhood and adolescent cancer.
In: Kliegman RM, Stanton BF, St. Geme JW, et al., eds.
Nelson
Textbook of Pediatrics
. 19th ed. Philadelphia, PA: W.B.
Saunders; 2011:1725–1727.
69. Smith LL. Molecular and cellular biology of cancer. In: Kliegman
RM, Stanton BF, St. Geme JW, et al., eds.
Nelson Textbook
of Pediatrics
. 19th ed. Philadelphia, PA: W.B. Saunders;
2011:1727–1728.
70. Richey K. Principles of diagnosis. In: Kliegman RM, Stanton BF,
St. Geme JW, et al., eds.
Nelson Textbook of Pediatrics
. 19th ed.
Philadelphia, PA: W.B. Saunders; 2011:1729–1731.
71. Fragkandrea J, Nixon JA, Panagopoulou P. Signs and symptoms
of childhood cancer: a guide to early recognition.
Am Fam
Physician.
2013;88(3):185–192.
72. Bleyer A, Rtchey AK. Principles of treatment. In: Kliegman
RM, Stanton BF, St. Geme JW, et al., eds.
Nelson Textbook
of Pediatrics
. 19th ed. Philadelphia, PA: W.B. Saunders;
2011:1732–1741.
73. Armstrong GT, Stoval M, Robison LL. Long-term effects of
radiation exposure among adult survivors of childhood cancer:
results from the childhood cancer survivors study.
Radiat Res
.
2010;17:840–850.
74. Schmidt D, Anderson LA, Bingen K. Late effects in adult
survivors of childhood cancer: Considerations for the general
practitioner.
Wis Med J.
2010;100(2):98–107.
75. Henderson TTO. Childhood cancer survivors: transition in
adult-focused risk-based care.
Pediatrics
. 2010;126:127–136.
76. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health
conditions in adult survivors of childhood cancer.
N Engl J Med
.
2006;355:1572–1582.
77. Cohen LE. Endocrine late effects of cancer treatment.
Endocrinol
Metab Clin North Am
. 2005;34:769–789.
Porth Essentials Resources
Explore these additional resources to enhance learning
for this chapter:
•
NCLEX-Style Questions and Other Resources
on
,
•
Study Guide for Essentials of Pathophysiology
•
Concepts in Action Animations
•
Adaptive Learning | Powered by PrepU,
prepu
